CUSIP: 640667101
Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,116,796
-
Share change
-
-208,558
-
Total reported value
-
$16,658,000
-
Price per share
-
$7.87
-
Number of holders
-
13
-
Value change
-
-$2,358,303
-
Number of buys
-
7
-
Number of sells
-
8
Quarterly Holders Quick Answers
What is CUSIP 640667101?
CUSIP 640667101 identifies NRXGQ - NEPHROGENEX INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2015
-
Previous quarter:
Q4 2014
Recent filing periods for CUSIP 640667101:
Institutional Holders of NEPHROGENEX INC - COM (NRXGQ) as of Q1 2015
As of 31 Mar 2015,
NEPHROGENEX INC - COM (NRXGQ) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,116,796 shares.
The largest 10 holders included
RHO CAPITAL PARTNERS INC, Visium Asset Management, LP, MORGAN STANLEY, TURNER INVESTMENTS, L.P., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, BlackRock Fund Advisors, UBS Group AG, and BlackRock Investment Management, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.